Immediate Impact
1 by Nobel laureates 4 from Science/Nature 53 standout
Citing Papers
Ultralight crystalline hybrid composite material for highly efficient sequestration of radioiodine
2024 Standout
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
2024 Standout
Works of Robert Matthew Strother being referenced
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
2015
Phase I study of REGN421 (R)/SAR153192, a fully-human delta-like ligand 4 (Dll4) monoclonal antibody (mAb), in patients with advanced solid tumors.
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert Matthew Strother | 292 | 80 | 101 | 281 | 46 | 870 | |
| Robert R. LaBadie | 186 | 61 | 67 | 230 | 51 | 1.0k | |
| Roberto Leone | 234 | 88 | 68 | 271 | 50 | 1.1k | |
| Céline Narjoz | 323 | 65 | 110 | 304 | 41 | 1.1k | |
| Jai N. Patel | 312 | 50 | 170 | 251 | 91 | 946 | |
| Huang Sm | 326 | 30 | 207 | 206 | 26 | 1.1k | |
| Rami Rahal | 370 | 45 | 73 | 387 | 43 | 913 | |
| Satjit Brar | 279 | 68 | 113 | 153 | 15 | 818 | |
| John Duan | 293 | 43 | 104 | 270 | 23 | 1.1k | |
| Marco H. Hofmann | 293 | 47 | 50 | 471 | 40 | 923 | |
| David L. DeRemer | 281 | 66 | 51 | 303 | 64 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...